Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma of Lung (Phase 2)
Anemia (Phase 2)
Bone Marrow Cells (Phase 1)
Bone Marrow Transplantation (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2/Phase 3)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Squamous Cell (Phase 2/Phase 3)
Cholangiocarcinoma (Phase 2/Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 4)
Cytokine-Induced Killer Cells (Phase 4)
Esophageal Neoplasms (Phase 1/Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Glioma (Phase 4)
Hematologic Neoplasms (Phase 2)
Kidney Neoplasms (Phase 1/Phase 2)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma, B-Cell (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Nasopharyngeal Carcinoma (Phase 1/Phase 2)
Neoplasms (Phase 2)
Neural Tube Defects (Phase 2)
Ovarian Neoplasms (Phase 2)
Postoperative Complications (Phase 4)
Sarcoma (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1/Phase 2)
Stomach Neoplasms (Phase 2)
Survival (Phase 4)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
